What is the survival rate for MDS by stage

Understanding MDS Survival Rates

I appreciate this important question. Let me explain what survival data for MDS actually looks like, because it's quite different from many other cancers.

Why MDS Doesn't Have Traditional "Stages"

MDS (myelodysplastic syndromes) isn't classified by stages like breast or lung cancer. Instead, doctors use risk stratification systems that predict how the disease will progress. This is actually more useful for MDS because the disease behavior varies so much between patients.

According to the NCCN Guidelines for Myelodysplastic Syndromes, the main risk categories are:

• Very-Low Risk
• Low Risk
• Intermediate Risk
• High Risk

These categories are determined by looking at:

• Blast percentage (immature blood cells in bone marrow)
• Cytogenetics (chromosome abnormalities)
• Molecular mutations (specific gene changes)
• Cytopenias (low blood cell counts)

What the Data Shows

The survival outlook varies dramatically based on risk category:

• Lower-risk MDS (very-low, low, and some intermediate-risk): Many patients live for several years to over a decade, with some never progressing to acute leukemia
• Higher-risk MDS: Median survival is typically shorter, often measured in months to a few years, with higher risk of transformation to acute myeloid leukemia (AML)

Important Context

According to NCCN Guidelines, survival depends heavily on:

1. Individual patient factors - age, overall health, comorbidities
2. Specific mutations present - certain mutations like TP53, ASXL1, or RUNX1 are associated with poorer prognosis
3. Response to treatment - how well the disease responds to therapies like hypomethylating agents (HMAs) or other targeted treatments
4. Cytogenetic findings - specific chromosome abnormalities significantly impact outlook

Why Individual Variation Matters

Two patients with the same "risk category" can have very different outcomes. The NCCN Guidelines emphasize that prognostic scoring systems provide estimates, not certainties. Your specific situation depends on your complete clinical picture.

Questions to Ask Your Doctor

To understand YOUR specific prognosis, ask:

1. What is my IPSS-R (Integrated Prognostic Scoring System-Revised) score, and what risk category does that put me in?
2. What specific mutations or cytogenetic abnormalities do I have, and how do those affect my outlook?
3. Based on my age and overall health, what is the typical survival range for someone in my situation?
4. What factors might improve or worsen my prognosis?
5. How will we monitor my disease, and what would trigger a change in treatment approach?

Where to Find More Information

The NCCN Guidelines for Myelodysplastic Syndromes (Version 1.2026) provide detailed prognostic information and include the IPSS-M Web calculator (https://mds-risk-model.com) that helps determine individual risk scores. The American Cancer Society also has patient-friendly MDS information.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.